SAN DIEGO--(BUSINESS WIRE)--Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology, and drug delivery markets, today announced that it plans to report its fourth quarter and full year 2008 financial results on Friday, March 13, 2009 before the open of the financial markets. The announcement will be followed by a conference call with the investment community at 8:00 a.m. PST, (11:00 a.m. EST) which will be simultaneously broadcast over the Internet. Management will discuss the financial results and highlights for the fourth quarter and full year 2008 and provide a product pipeline update.
